Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
27,240
Total Claims
$1.5M
Drug Cost
422
Beneficiaries
$3,484
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-93%
Opioid rate vs peers
0.2% vs 2.2% avg
+147%
Cost per patient vs peers
$3,484 vs $1,411 avg
+3%
Brand preference vs peers
11.0% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
44
Opioid Claims
$365
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,980 claims · $1.1M
Generic: 24,205 claims · $355K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 886 | $193K |
| Paliperidone Palmitate | 33 | $110K |
| Apixaban | 266 | $68K |
| Linagliptin | 189 | $38K |
| Insulin Glargine,hum.Rec.Anlog | 113 | $36K |
| Fluticasone/Vilanterol | 82 | $32K |
| Insulin Aspart | 98 | $30K |
| Atorvastatin Calcium | 2,951 | $21K |
| Insulin Lispro | 70 | $21K |
| Chlorpromazine Hcl | 69 | $19K |
| Budesonide/Formoterol Fumarate | 46 | $18K |
| Empagliflozin | 104 | $18K |
| Linaclotide | 25 | $13K |
| Lipase/Protease/Amylase | 12 | $13K |
| Potassium Chloride | 237 | $11K |
Prescribing Profile
Patient Profile
66
Avg Age
43%
Female
1.98
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data